iBio Inc

iBio Inc is a US biotechnology company focused on developing and manufacturing biopharmaceuticals using its proprietary plant-based platforms. Its primary aim is to provide rapid and scalable solutions for the production of advanced therapeutics. The company aims to serve clients globally. Operating within the biopharmaceutical sector, iBio Inc specialises in leveraging its FastPharming® system. This approach aims to accelerate drug development and manufacturing, potentially bringing novel therapies to market more efficiently for a range of medical needs. Keep up to date on the latest share price changes by adding IBIO stock to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.